Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.270
-0.020 (-1.55%)
At close: Aug 7, 2025, 4:00 PM
1.241
-0.029 (-2.29%)
After-hours: Aug 7, 2025, 5:07 PM EDT
MoneyLion Market Cap
Acrivon Therapeutics has a market cap or net worth of $39.82 million as of August 7, 2025. Its market cap has decreased by -83.01% in one year.
Market Cap
39.82M
Enterprise Value
-106.30M
1-Year Change
-83.01%
Ranking
Category
Stock Price
$1.27
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $39.82M, a decrease of -83.06%. That is a compound annual growth rate of -47.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 39.82M | -78.76% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.60B |
| Johnson & Johnson | 410.60B |
| AbbVie | 347.66B |
| AstraZeneca | 228.71B |
| Abbott Laboratories | 228.23B |
| Novartis AG | 221.76B |
| UnitedHealth Group | 219.26B |
| Novo Nordisk | 200.63B |